Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury

Sci Rep. 2015 Mar 3:5:8718. doi: 10.1038/srep08718.

Abstract

Conditioned medium from mesenchymal stem cells (MSC-CM) may represent a promising alternative to MSCs transplantation, however, the low concentrations of growth factors in non-activated MSC-CM hamper its clinical application. Recent data indicated that the paracrine potential of MSCs could be enhanced by inflammatory factors. Herein, we pre-activated bone-marrow-derived MSCs under radiation-induced inflammatory condition (MSC(IEC-6(IR))) and investigated the evidence and mechanism for the differential effects of MSC-CM(IEC-6(IR)) and non-activated MSC-CM on radiation-induced intestinal injury (RIII). Systemic infusion of MSC-CM(IEC-6(IR)), but not non-activated MSC-CM, dramatically improved intestinal damage and survival of irradiated rats. Such benefits may involve the modulation of epithelial regeneration and inflammation, as indicated by the regeneration of intestinal epithelial/stem cells, the regulation of the pro-/anti-inflammatory cytokine balance. The mechanism for the superior paracrine efficacy of MSC(IEC-6(IR)) is related to a higher secretion of regenerative, immunomodulatory and trafficking molecules, including the pivotal factor IGF-1, induced by TNF-α, IL-1β and nitric oxide partially via a heme oxygenase-1 dependent mechanism. Together, our findings suggest that pre-activation of MSCs with TNF-α, IL-1β and nitric oxide enhances its paracine effects on RIII via a heme oxygenase-1 dependent mechanism, which may help us to maximize the paracrine potential of MSCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / radiation effects
  • Cell Proliferation / drug effects
  • Cell Proliferation / radiation effects
  • Culture Media, Conditioned / pharmacology*
  • Heme Oxygenase-1 / metabolism
  • Inflammation / etiology
  • Inflammation / metabolism
  • Inflammation Mediators / metabolism
  • Insulin-Like Growth Factor I / pharmacology
  • Interleukin-1beta / metabolism*
  • Intestinal Diseases / drug therapy
  • Intestinal Diseases / mortality
  • Intestinal Diseases / pathology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / radiation effects
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism*
  • Nitric Oxide / metabolism*
  • Paracrine Communication*
  • Radiation Dosage
  • Radiation Injuries, Experimental / drug therapy
  • Radiation Injuries, Experimental / mortality
  • Radiation Injuries, Experimental / pathology
  • Rats
  • Regeneration / drug effects
  • Stem Cells / drug effects
  • Stem Cells / metabolism
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Culture Media, Conditioned
  • Inflammation Mediators
  • Interleukin-1beta
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Insulin-Like Growth Factor I
  • Heme Oxygenase-1